OS was significantly improved with enzalutamide over placebo in patients < @ years -LSB- median not yet reached versus @ months ; HR @ ( @ % CI @-@ @ ) , P < @ -RSB- and in patients @ years -LSB- median @ versus @ months ; HR @ ( @ % CI @-@ @ ) , P = @ -RSB- , respectively .